Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma

Hedy L. Kindler, Theodore G. Karrison, David R. Gandara, Charles Lu, Lee M. Krug, James P. Stevenson, Pasi A. Jänne, David I. Quinn, Marianna N. Koczywas, Julie R. Brahmer, Kathy S. Albain, David A. Taber, Samuel G. Armato, Nicholas J. Vogelzang, Helen X. Chen, Walter M. Stadler, Everett E. Vokes

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma'. Together they form a unique fingerprint.

Medicine & Life Sciences